Logo image of LNA.PA

LNA SANTE (LNA.PA) Stock Fundamental Analysis

Europe - EPA:LNA - FR0004170017 - Common Stock

22.7 EUR
-0.1 (-0.44%)
Last: 10/24/2025, 7:00:00 PM
Fundamental Rating

4

Taking everything into account, LNA scores 4 out of 10 in our fundamental rating. LNA was compared to 27 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of LNA while its profitability can be described as average. LNA is valued quite cheap, while showing a decent growth score. This is a good combination! LNA also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

LNA had positive earnings in the past year.
LNA had a positive operating cash flow in the past year.
In the past 5 years LNA has always been profitable.
LNA had a positive operating cash flow in each of the past 5 years.
LNA.PA Yearly Net Income VS EBIT VS OCF VS FCFLNA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

1.2 Ratios

LNA has a worse Return On Assets (1.42%) than 74.19% of its industry peers.
With a Return On Equity value of 6.95%, LNA perfoms like the industry average, outperforming 51.61% of the companies in the same industry.
With a Return On Invested Capital value of 3.65%, LNA is not doing good in the industry: 61.29% of the companies in the same industry are doing better.
Measured over the past 3 years, the Average Return On Invested Capital for LNA is below the industry average of 5.99%.
Industry RankSector Rank
ROA 1.42%
ROE 6.95%
ROIC 3.65%
ROA(3y)1.56%
ROA(5y)1.35%
ROE(3y)7.9%
ROE(5y)7.74%
ROIC(3y)3.69%
ROIC(5y)3.39%
LNA.PA Yearly ROA, ROE, ROICLNA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

LNA has a Profit Margin (2.70%) which is comparable to the rest of the industry.
LNA's Profit Margin has declined in the last couple of years.
The Operating Margin of LNA (8.28%) is better than 70.97% of its industry peers.
LNA's Operating Margin has declined in the last couple of years.
LNA has a better Gross Margin (89.45%) than 90.32% of its industry peers.
LNA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 8.28%
PM (TTM) 2.7%
GM 89.45%
OM growth 3Y0.38%
OM growth 5Y-4.37%
PM growth 3Y-7.43%
PM growth 5Y-7.27%
GM growth 3Y1.46%
GM growth 5Y0.83%
LNA.PA Yearly Profit, Operating, Gross MarginsLNA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

2

2. Health

2.1 Basic Checks

LNA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for LNA remains at a similar level compared to 1 year ago.
The number of shares outstanding for LNA has been increased compared to 5 years ago.
The debt/assets ratio for LNA has been reduced compared to a year ago.
LNA.PA Yearly Shares OutstandingLNA.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
LNA.PA Yearly Total Debt VS Total AssetsLNA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

LNA has an Altman-Z score of 0.93. This is a bad value and indicates that LNA is not financially healthy and even has some risk of bankruptcy.
LNA's Altman-Z score of 0.93 is on the low side compared to the rest of the industry. LNA is outperformed by 70.97% of its industry peers.
LNA has a debt to FCF ratio of 7.86. This is a slightly negative value and a sign of low solvency as LNA would need 7.86 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 7.86, LNA is in the better half of the industry, outperforming 61.29% of the companies in the same industry.
LNA has a Debt/Equity ratio of 2.19. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of LNA (2.19) is worse than 77.42% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.19
Debt/FCF 7.86
Altman-Z 0.93
ROIC/WACC0.96
WACC3.8%
LNA.PA Yearly LT Debt VS Equity VS FCFLNA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.3 Liquidity

A Current Ratio of 0.91 indicates that LNA may have some problems paying its short term obligations.
LNA has a Current ratio (0.91) which is comparable to the rest of the industry.
A Quick Ratio of 0.47 indicates that LNA may have some problems paying its short term obligations.
LNA has a Quick ratio of 0.47. This is amonst the worse of the industry: LNA underperforms 87.10% of its industry peers.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.47
LNA.PA Yearly Current Assets VS Current LiabilitesLNA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

5

3. Growth

3.1 Past

The earnings per share for LNA have decreased by -6.83% in the last year.
Measured over the past years, LNA shows a decrease in Earnings Per Share. The EPS has been decreasing by -0.23% on average per year.
LNA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.58%.
Measured over the past years, LNA shows a quite strong growth in Revenue. The Revenue has been growing by 8.85% on average per year.
EPS 1Y (TTM)-6.83%
EPS 3Y-4.5%
EPS 5Y-0.23%
EPS Q2Q%-17.9%
Revenue 1Y (TTM)9.58%
Revenue growth 3Y5.37%
Revenue growth 5Y8.85%
Sales Q2Q%11.97%

3.2 Future

LNA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.18% yearly.
LNA is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.68% yearly.
EPS Next Y3.24%
EPS Next 2Y14.2%
EPS Next 3Y14.18%
EPS Next 5YN/A
Revenue Next Year11.53%
Revenue Next 2Y9.29%
Revenue Next 3Y7.68%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
LNA.PA Yearly Revenue VS EstimatesLNA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
LNA.PA Yearly EPS VS EstimatesLNA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 10.66, which indicates a very decent valuation of LNA.
87.10% of the companies in the same industry are more expensive than LNA, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of LNA to the average of the S&P500 Index (26.89), we can say LNA is valued rather cheaply.
The Price/Forward Earnings ratio is 9.33, which indicates a very decent valuation of LNA.
Compared to the rest of the industry, the Price/Forward Earnings ratio of LNA indicates a rather cheap valuation: LNA is cheaper than 83.87% of the companies listed in the same industry.
LNA's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.99.
Industry RankSector Rank
PE 10.66
Fwd PE 9.33
LNA.PA Price Earnings VS Forward Price EarningsLNA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, LNA is valued cheaper than 90.32% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, LNA is valued cheaply inside the industry as 93.55% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 2.47
EV/EBITDA 5.36
LNA.PA Per share dataLNA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as LNA's earnings are expected to grow with 14.18% in the coming years.
PEG (NY)3.29
PEG (5Y)N/A
EPS Next 2Y14.2%
EPS Next 3Y14.18%

7

5. Dividend

5.1 Amount

LNA has a Yearly Dividend Yield of 2.85%. Purely for dividend investing, there may be better candidates out there.
LNA's Dividend Yield is rather good when compared to the industry average which is at 2.53. LNA pays more dividend than 83.87% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.31, LNA pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.85%

5.2 History

On average, the dividend of LNA grows each year by 9.57%, which is quite nice.
Dividend Growth(5Y)9.57%
Div Incr Years3
Div Non Decr Years3
LNA.PA Yearly Dividends per shareLNA.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

28.13% of the earnings are spent on dividend by LNA. This is a low number and sustainable payout ratio.
LNA's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP28.13%
EPS Next 2Y14.2%
EPS Next 3Y14.18%
LNA.PA Yearly Income VS Free CF VS DividendLNA.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
LNA.PA Dividend Payout.LNA.PA Dividend Payout, showing the Payout Ratio.LNA.PA Dividend Payout.PayoutRetained Earnings

LNA SANTE

EPA:LNA (10/24/2025, 7:00:00 PM)

22.7

-0.1 (-0.44%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)07-24 2025-07-24
Earnings (Next)02-04 2026-02-04
Inst Owners9.22%
Inst Owner ChangeN/A
Ins Owners1.23%
Ins Owner ChangeN/A
Market Cap243.12M
Revenue(TTM)806.60M
Net Income(TTM)21.82M
Analysts84.44
Price Target31.62 (39.3%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.85%
Yearly Dividend0.6
Dividend Growth(5Y)9.57%
DP28.13%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.27%
PT rev (3m)-0.64%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-11.31%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.11%
Revenue NY rev (3m)-0.75%
Valuation
Industry RankSector Rank
PE 10.66
Fwd PE 9.33
P/S 0.3
P/FCF 2.47
P/OCF 2.2
P/B 0.77
P/tB N/A
EV/EBITDA 5.36
EPS(TTM)2.13
EY9.38%
EPS(NY)2.43
Fwd EY10.71%
FCF(TTM)9.18
FCFY40.42%
OCF(TTM)10.31
OCFY45.43%
SpS75.31
BVpS29.3
TBVpS-24.71
PEG (NY)3.29
PEG (5Y)N/A
Graham Number37.47
Profitability
Industry RankSector Rank
ROA 1.42%
ROE 6.95%
ROCE 5.93%
ROIC 3.65%
ROICexc 3.89%
ROICexgc 7.89%
OM 8.28%
PM (TTM) 2.7%
GM 89.45%
FCFM 12.18%
ROA(3y)1.56%
ROA(5y)1.35%
ROE(3y)7.9%
ROE(5y)7.74%
ROIC(3y)3.69%
ROIC(5y)3.39%
ROICexc(3y)3.98%
ROICexc(5y)3.73%
ROICexgc(3y)8.5%
ROICexgc(5y)8.01%
ROCE(3y)5.91%
ROCE(5y)5.67%
ROICexgc growth 3Y1.6%
ROICexgc growth 5Y1.57%
ROICexc growth 3Y2.72%
ROICexc growth 5Y-1.59%
OM growth 3Y0.38%
OM growth 5Y-4.37%
PM growth 3Y-7.43%
PM growth 5Y-7.27%
GM growth 3Y1.46%
GM growth 5Y0.83%
F-Score5
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 2.19
Debt/FCF 7.86
Debt/EBITDA 4.33
Cap/Depr 13.25%
Cap/Sales 1.51%
Interest Coverage 2.34
Cash Conversion 69.64%
Profit Quality 450.48%
Current Ratio 0.91
Quick Ratio 0.47
Altman-Z 0.93
F-Score5
WACC3.8%
ROIC/WACC0.96
Cap/Depr(3y)14.64%
Cap/Depr(5y)16.09%
Cap/Sales(3y)1.69%
Cap/Sales(5y)1.89%
Profit Quality(3y)386.77%
Profit Quality(5y)628.45%
High Growth Momentum
Growth
EPS 1Y (TTM)-6.83%
EPS 3Y-4.5%
EPS 5Y-0.23%
EPS Q2Q%-17.9%
EPS Next Y3.24%
EPS Next 2Y14.2%
EPS Next 3Y14.18%
EPS Next 5YN/A
Revenue 1Y (TTM)9.58%
Revenue growth 3Y5.37%
Revenue growth 5Y8.85%
Sales Q2Q%11.97%
Revenue Next Year11.53%
Revenue Next 2Y9.29%
Revenue Next 3Y7.68%
Revenue Next 5YN/A
EBIT growth 1Y5.74%
EBIT growth 3Y5.76%
EBIT growth 5Y4.09%
EBIT Next Year127.78%
EBIT Next 3Y38.33%
EBIT Next 5YN/A
FCF growth 1Y16.06%
FCF growth 3Y14.06%
FCF growth 5Y-2.49%
OCF growth 1Y13.27%
OCF growth 3Y11.38%
OCF growth 5Y-1.32%

LNA SANTE / LNA.PA FAQ

What is the ChartMill fundamental rating of LNA SANTE (LNA.PA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to LNA.PA.


Can you provide the valuation status for LNA SANTE?

ChartMill assigns a valuation rating of 7 / 10 to LNA SANTE (LNA.PA). This can be considered as Undervalued.


How profitable is LNA SANTE (LNA.PA) stock?

LNA SANTE (LNA.PA) has a profitability rating of 4 / 10.


What is the valuation of LNA SANTE based on its PE and PB ratios?

The Price/Earnings (PE) ratio for LNA SANTE (LNA.PA) is 10.66 and the Price/Book (PB) ratio is 0.77.


Can you provide the expected EPS growth for LNA stock?

The Earnings per Share (EPS) of LNA SANTE (LNA.PA) is expected to grow by 3.24% in the next year.